Table 1.
Baseline characteristics stratified by baseline hsCRP.
| hsCRP |
P value | |||
|---|---|---|---|---|
| <1 mg/L [n = 132] | 1 – 3 mg/L [n = 170] | >3 mg/L [n = 111] | ||
| Age (years) | 59.7 ± 9.3 | 59.0 ± 9.6 | 60.0 ± 9.4 | 0.62 |
| Female, % (N) | 22.7 (30) | 27.6 (47) | 33.3 (37) | 0.18 |
| Medical history | ||||
| - MI, % (N) | 35.6 (47) | 32.4 (55) | 30.6 (34) | 0.70 |
| - CABG, % (N) | 0.8 [1] | 0.6 [1] | 0.9 [1] | 1.00 |
| - PCI, % (N) | 37.9 (50) | 45.9 (78) | 29.7 (33) | 0.02 |
| - CeVD, % (N) | 3.0 [4] | 2.9 [5] | 2.7 [3] | 1.00 |
| - PAD, % (N) | 2.3 [3] | 1.8 [3] | 3.6 [4] | 0.66 |
| Risk factors | ||||
| - Type II DM, % (N) | 14.4 [19] | 23.5 (40) | 24.3 [27] | 0.09 |
| - Current smoker, % (N) | 25.0 (33) | 28.2 (48) | 23.4 [26] | 0.64 |
| - Hypertension, % (N) | 72.7 (96) | 83.5 (142) | 86.5 (96) | 0.01 |
| - FHx CAD, % (N) | 41.7 (55) | 33.5 (57) | 29.7 (33) | 0.13 |
| - Metabolic Syndrome, % (N) | 28.0 (37) | 35.3 (60) | 41.4 (46) | 0.09 |
| Anthropometric/BP | ||||
| - SBP, mmHg ± SD | 130 ± 15 | 131 ± 14 | 133 ± 15 | 0.32 |
| - DBP mmHg ± SD | 78 ± 9 | 78 ± 9 | 78 ± 10 | 0.90 |
| - BMI, kg/m2 (Q1,Q3) | 26.8 (24.5,29.7) | 28.8 (26.3,32.6) | 30.2 (27.0,34.3) | <0.01 |
| Medications | ||||
| - Statin, % (N) | 99.2 (131) | 98.8 (168) | 98.2 (109) | 0.74 |
| - Ezetimibe, % (N) | 2.3 [3] | 2.9 [5] | 0 (0) | 0.20 |
| - Antiplatelets, % (N) | 93.9 (124) | 95.3 (162) | 90.1 (100) | 0.22 |
| - Beta blockers, % (N) | 68.2 (90) | 78.8 (134) | 75.7 (84) | 0.10 |
| - ACE/ARB, % (N) | 60.1 (80) | 72.9 (124) | 82.9 (92) | 0.08 |
| Metabolic | ||||
| - LDL-C, mg/dL ± SD | 90.1 ± 24.7 | 92.7 ± 28.6 | 92.7 ± 27.9 | 0.65 |
| - HDL-C, mg/dL ± SD | 49.4 ± 13.5 | 47.0 ± 12.7 | 42.3 ± 10.2 | <0.01 |
| - TG, mg/dL (Q1,Q3) | 118.6 (79,137) | 125.0 (93,167) | 128.0 (95,195) | <0.01 |
| - HbA1c, % ± SD | 5.7 ± 0.6 | 5.9 ± 0.8 | 5.9 ± 0.8 | 0.03 |
Characteristics presented as median (Q1,Q3) or mean ± SD.
ACE/ARB – angiotensin converting enzyme inhibitor or angiotensin-II receptor antagonist; BMI – body mass index; CABG – coronary artery bypass surgery; CeVD – cerebrovascular disease; DBP - diastolic blood pressure; FHx CAD – family history of coronary artery disease; HDL-C – high density lipoprotein cholesterol; LDL-C – low-density lipoprotein cholesterol; MI – myocardial infarction; PAD – peripheral arterial disease; PCI – percutaneous coronary intervention; SBP – systolic blood pressure; TG - triglycerides.